Tongxin Finance APP News, Aidi Pharmaceutical (688488.SH) announced that one of the company’s actual controllers and Chairman, Mr. Fu Heliang (hereinafter referred to as the “Increase Subject”), plans to increase holdings of the company’s shares within six months starting from March 2, 2026, through methods permitted by the Shanghai Stock Exchange trading system (including but not limited to centralized bidding and block trades). The planned increase amount is not less than RMB 10 million (inclusive) and not more than RMB 15 million (inclusive).
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Aidi Pharmaceuticals (688488.SH)'s actual controller, Fu Heliang, plans to increase his stake in the company by 10 million to 15 million yuan
Tongxin Finance APP News, Aidi Pharmaceutical (688488.SH) announced that one of the company’s actual controllers and Chairman, Mr. Fu Heliang (hereinafter referred to as the “Increase Subject”), plans to increase holdings of the company’s shares within six months starting from March 2, 2026, through methods permitted by the Shanghai Stock Exchange trading system (including but not limited to centralized bidding and block trades). The planned increase amount is not less than RMB 10 million (inclusive) and not more than RMB 15 million (inclusive).